Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
MSFT -7.97META 2.815BKNG 0.45HMP.TO 0SPGP 0.19ZUQ.TO -0.34NVDA -3.89GL 0.93
Valeant Pharmaceuticals (VRX.TO)

Valeant Pharmaceuticals (VRX.TO)

0.00
-0.00 (0.00%)
39 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
BUY

Valeant Pharmaceuticals(VRX.TO)

Aug 29, 2001
A lot of innovative products. Has performed well. A good long term hold.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$74.50

Stock price when the opinion was issued

Healthcare
PAST TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Aug 20, 2001
(Was a top pick on Feb 21/01 no change) A key holding in their funds. Good valuation.
Photo of Glenn Paradis, BA, CFAGlenn Paradis, BA, CFAUnlock Rating
$68.76

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Aug 10, 2001
Too expensive and not enough product lines.
Photo of David DriscollDavid DriscollUnlock Rating
$68.95

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Aug 10, 2001
Prefers over MDS.
Photo of Steven WipperstegSteven WipperstegUnlock Rating
$68.95

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Aug 03, 2001
Reasonably priced. Relatively profitable. Caution.
Photo of Robert McWhirterRobert McWhirterUnlock Rating
$70.88

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Jul 31, 2001
A leader in this sector. Good product and sales force.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$72.00

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Jul 30, 2001
Good value. Fundamental values are good. Long term hold.
Photo of Steven WipperstegSteven WipperstegUnlock Rating
$70.11

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Jun 26, 2001
Good diversification in drugs.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$65.60

Stock price when the opinion was issued

Healthcare
DON'T BUY

Valeant Pharmaceuticals(VRX.TO)

Jun 25, 2001
Has upside potential. Price to book is 8/9 and is risky.
Photo of Ross HealyRoss HealyUnlock Rating
$66.40

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Jun 25, 2001
Has had a good run, but still has growth.
Photo of John ZechnerJohn ZechnerUnlock Rating
$66.40

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Jun 20, 2001
Prefers over QLT.
Photo of David BurrowsDavid BurrowsUnlock Rating
$64.30

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

Jun 06, 2001
Likes. One of the better techs. Good product.
Photo of John Sinkins, CFAJohn Sinkins, CFAUnlock Rating
$64.00

Stock price when the opinion was issued

Healthcare
BUY

Valeant Pharmaceuticals(VRX.TO)

May 15, 2001
Has some growth left.
Photo of Ross HealyRoss HealyUnlock Rating
$57.51

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

May 09, 2001
Not a well known stock. Made a good acquisition.
Photo of Gavin GrahamGavin GrahamUnlock Rating
$57.57

Stock price when the opinion was issued

Healthcare
TOP PICK

Valeant Pharmaceuticals(VRX.TO)

Apr 05, 2001
Reported patent concerns will probably be a minor issue. Will have sustainable earnings growth. Not susceptible to market swings. Good earnings.
Photo of Martin Hubbes, CFAMartin Hubbes, CFAUnlock Rating
$53.00

Stock price when the opinion was issued

Healthcare
Showing 676 to 690 of 714 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

FCX -0.2$69.93
MU -41.09$1046.9
WDC 45.93$699.46
AAPL 2.53$298.95
SPCX 23.15$215.65
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

Today's Top Picks

MSFT -7.97$391.79
META 2.815$596.295
BKNG 0.45$175.09
HMP.TO 0$9.76
SPGP 0.19$121.79

Popular Articles

Latest Sell Signals

CRWD -11.56$681.35
MSFT -7.97$391.79
SCCO -0.2$193.02
ADBE 1.82$208.18
PEP 0.195$146.445

Most Recent Experts

Joe Terranova

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Gordon Reid

Gordon Reid

GoodReid Investment Counsel

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video